Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel V T Catenacci

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Molecular Oncology|January 6, 2015
Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneityDaniel V T Catenacci
JCO Precision Oncology|April 19, 2019
When Inhibitor MET Biomarker: Postmortem or Initium Novum?Daniel V T Catenacci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2021
A PERFECT Biomarker-focused Study of Neoadjuvant IO for Esophagogastric CancerDaniel V T Catenacci
The Lancet. Oncology|September 7, 2015
Expansion platform type II: testing a treatment strategyDaniel V T Catenacci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2021
Exploring New Approaches for Locally Advanced Gastroesophageal Adenocarcinomas: TNT, Irinotecan, and ctDNADaniel V T Catenacci
Discovery Medicine|September 4, 2013
Gastroesophageal cancer: focus on epidemiology, classification, and stagingAmikar Sehdev, Daniel V T Catenacci
Journal of Hematology & Oncology|September 10, 2013
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of careAmikar Sehdev, Daniel V T Catenacci
Archives of Pathology & Laboratory Medicine|August 29, 2014
Next-generation companion diagnostics: promises, challenges, and solutionsJoseph D Khoury, Daniel V T Catenacci
Surgical Oncology Clinics of North America|March 11, 2017
Novel Targeted Therapies for Esophagogastric CancerSteven B Maron, Daniel V T Catenacci
Blood Reviews|May 12, 2005
Myelodysplasic syndromes: a comprehensive reviewDaniel V T Catenacci, Gary J Schiller
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Molecular Oncology|January 6, 2015
Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneityDaniel V T Catenacci
JCO Precision Oncology|April 19, 2019
When Inhibitor MET Biomarker: Postmortem or Initium Novum?Daniel V T Catenacci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2021
A PERFECT Biomarker-focused Study of Neoadjuvant IO for Esophagogastric CancerDaniel V T Catenacci
The Lancet. Oncology|September 7, 2015
Expansion platform type II: testing a treatment strategyDaniel V T Catenacci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2021
Exploring New Approaches for Locally Advanced Gastroesophageal Adenocarcinomas: TNT, Irinotecan, and ctDNADaniel V T Catenacci
Discovery Medicine|September 4, 2013
Gastroesophageal cancer: focus on epidemiology, classification, and stagingAmikar Sehdev, Daniel V T Catenacci
Journal of Hematology & Oncology|September 10, 2013
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of careAmikar Sehdev, Daniel V T Catenacci
Archives of Pathology & Laboratory Medicine|August 29, 2014
Next-generation companion diagnostics: promises, challenges, and solutionsJoseph D Khoury, Daniel V T Catenacci
Surgical Oncology Clinics of North America|March 11, 2017
Novel Targeted Therapies for Esophagogastric CancerSteven B Maron, Daniel V T Catenacci
Blood Reviews|May 12, 2005
Myelodysplasic syndromes: a comprehensive reviewDaniel V T Catenacci, Gary J Schiller
Pageof 7